Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression (Q39532426)

12 September 2017

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression (English)

1 reference

12 September 2017

1 reference

F Lamers

1

0 references

Aartjan T.F. Beekman

series ordinal

5

object named as

A T F Beekman

1 reference

12 September 2017

6

B W J H Penninx

1 reference

12 September 2017

N Vogelzangs

2

1 reference

12 September 2017

K R Merikangas

series ordinal

3

1 reference

12 September 2017

P de Jonge

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

23 October 2012

1 reference

12 September 2017

1 reference

12 September 2017

18

1 reference

12 September 2017

6

1 reference

12 September 2017

692-699

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2012.144

12 September 2017

0 references

cites work

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Prevalence of the metabolic syndrome in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Associations between anxiety, depression, and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Role of cytokines in atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

The subtypes of major depression in a twin registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Meta-review of depressive subtyping models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Atypical depression: useful concept, but it's time to revise the DSM-IV criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Atypical depression: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Toward validation of atypical depression in the community: results of the Zurich cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Latent class analysis of lifetime depressive symptoms in the national comorbidity survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Recurrence in major depression: a conceptual analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Is depression a chronic mental illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Genetics of recurrent early-onset depression (GenRED): design and preliminary clinical characteristics of a repository sample for genetic linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Salivary cortisol in psychoneuroendocrine research: recent developments and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Automated measurement of salivary cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Genetic linkage study of panic: clinical methodology and description of pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Antidepressant use and salivary cortisol in depressive and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Nicotinic receptor-mediated effects on appetite and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

The associations between psychopathology and being overweight: a 20-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

White adipose tissue as endocrine organ and its role in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Acute inflammation and negative mood: mediation by cytokine activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Clinical depression and inflammatory risk markers for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

The impact of treatment on HPA axis activity in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Which endogenous depressive symptoms relate to REM latency reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

HPA axis and sleep: identifying subtypes of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Sleep and circadian rhythms in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Atypical depressive syndromes in varying definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

7 January 2021

Partial validation of the atypical features subtype of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

7 January 2021

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

7 January 2021

Inflammatory mechanisms in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.144

7 January 2021

Identifiers

DOI

10.1038/MP.2012.144

1 reference

12 September 2017

1 reference